密度 | 1.076g/cm3 |
---|---|
沸点 | 396.7?C at 760mmHg |
分子式 | C12H32N4O3P2 |
分子量 | 342.35500 |
闪点 | 193.7?C |
精确质量 | 342.19500 |
PSA | 111.11000 |
LogP | 4.77480 |
折射率 | 1.461 |
计算化学 |
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:7 4.可旋转化学键数量:5 5.互变异构体数量:4 6.拓扑分子极性表面积132 7.重原子数量:25 8.表面电荷:0 9.复杂度:616 10.同位素原子数量:0 11.确定原子立构中心数量:3 12.不确定原子立构中心数量:1 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS06 |
---|---|
信号词 |
Danger |
危害声明 |
H300-H310-H330 |
警示性声明 |
P260-P264-P280-P284-P302 + P350-P310 |
个人防护装备 |
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) |
T+ |
风险声明 (欧洲) |
26/27/28 |
安全声明 (欧洲) |
S22-S45-S36-S37-S39 |
危险品运输编码 | UN 2811 6.1/PG 1 |
Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease. Chem. Biol. Drug Des. 86 , 1168-77, (2015)
A series of scutellarein carbamate derivatives were designed and synthesized based on the multitarget-directed drug design strategy for treatment of Alzheimer’s disease. Their acetylcholinesterase and…
|
|
Synthetic cannabimimetic agents metabolized by carboxylesterases. Drug Test. Anal. 7 , 565-76, (2015)
Synthetic cannabimimetic agents are a large group of diverse compounds which act as agonists at cannabinoid receptors. Since 2004, synthetic cannabinoids have been used recreationally, although severa…
|
|
Higher sensitivity to cadmium induced cell death of basal forebrain cholinergic neurons: A cholinesterase dependent mechanism Toxicology 325 , 151-9, (2014)
Cadmium is an environmental pollutant, which is a cause of concern because it can be greatly concentrated in the organism causing severe damage to a variety of organs including the nervous system whic…
|
|
MFCD00048272 |
EINECS 208-149-5 |
(2S,5R,6R)-3,3-dimethyl-4,7-dioxo-6-[(2-phenoxyacetyl)amino]-4λ<sup>4</sup>-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
Tetra(monoisopropyl)pyrophosphortetramide iso-OMPA |